Occupe actuellement un poste chez Tricida Inc
Position | Company | Period |
---|---|---|
Independent Director | Tricida Inc | 1 janvier 2014 - |
Independent Director | SI-BONE Inc | 1 avril 2014 - 13 juin 2019 |
Independent Director | Loxo Oncology Inc | 1 septembre 2013 - 22 décembre 2017 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2023-05-24 | 2023-05-22 |
Prelude Therapeutics Inc
(PRLD)
|
A Achat |
869 565
+9.4%
5,754 999 999 USD |
869 565 +9.4% | 5,75 | 4 999 999 USD | |
2022-11-25 | 2022-11-25 |
Tricida Inc
(TCDA)
|
V Vente |
3 629 226
-100.0%
0,22798 430 USD |
3 629 226 -100.0% | 0,22 | 798 430 USD | |
2022-11-25 | 2022-11-23 |
Tricida Inc
(TCDA)
|
V Vente |
5 617 300
-60.8%
0,211 179 633 USD |
5 617 300 -60.8% | 0,21 | 1 179 633 USD | |
2022-11-25 | 2022-11-22 |
Tricida Inc
(TCDA)
|
V Vente |
1 034 421
-10.1%
0,22227 573 USD |
1 034 421 -10.1% | 0,22 | 227 573 USD | |
2022-09-21 | 2022-09-19 |
Third Harmonic Bio Inc
(THRD)
|
A Achat |
300 000
+5.5%
17,005 100 000 USD |
300 000 +5.5% | 17,00 | 5 100 000 USD | |
2021-08-30 | 2021-08-30 |
Repare Therapeutics Inc
(RPTX)
|
VP Vente planifiée |
197
-0.2%
33,926 682 USD |
197 -0.2% | 33,92 | 6 682 USD | |
2021-08-30 | 2021-08-30 |
Repare Therapeutics Inc
(RPTX)
|
VP Vente planifiée |
6 500
-0.2%
33,92220 480 USD |
6 500 -0.2% | 33,92 | 220 480 USD | |
2021-08-30 | 2021-08-27 |
Repare Therapeutics Inc
(RPTX)
|
VP Vente planifiée |
209
-0.2%
33,947 093 USD |
209 -0.2% | 33,94 | 7 093 USD | |
2021-08-30 | 2021-08-27 |
Repare Therapeutics Inc
(RPTX)
|
VP Vente planifiée |
6 884
-0.2%
33,94233 643 USD |
6 884 -0.2% | 33,94 | 233 643 USD | |
2021-08-30 | 2021-08-26 |
Repare Therapeutics Inc
(RPTX)
|
VP Vente planifiée |
126
-0.1%
34,524 350 USD |
126 -0.1% | 34,52 | 4 350 USD | |
2021-08-30 | 2021-08-26 |
Repare Therapeutics Inc
(RPTX)
|
VP Vente planifiée |
4 157
-0.1%
34,52143 500 USD |
4 157 -0.1% | 34,52 | 143 500 USD | |
2021-08-25 | 2021-08-25 |
Repare Therapeutics Inc
(RPTX)
|
VP Vente planifiée |
208
-0.2%
34,347 143 USD |
208 -0.2% | 34,34 | 7 143 USD | |
2021-08-25 | 2021-08-25 |
Repare Therapeutics Inc
(RPTX)
|
VP Vente planifiée |
6 874
-0.2%
34,34236 053 USD |
6 874 -0.2% | 34,34 | 236 053 USD | |
2021-08-25 | 2021-08-24 |
Repare Therapeutics Inc
(RPTX)
|
VP Vente planifiée |
119
-0.1%
34,074 054 USD |
119 -0.1% | 34,07 | 4 054 USD | |
2021-08-25 | 2021-08-24 |
Repare Therapeutics Inc
(RPTX)
|
VP Vente planifiée |
3 920
-0.1%
34,07133 554 USD |
3 920 -0.1% | 34,07 | 133 554 USD | |
2021-08-25 | 2021-08-23 |
Repare Therapeutics Inc
(RPTX)
|
VP Vente planifiée |
209
-0.2%
34,067 119 USD |
209 -0.2% | 34,06 | 7 119 USD | |
2021-08-25 | 2021-08-23 |
Repare Therapeutics Inc
(RPTX)
|
VP Vente planifiée |
6 885
-0.2%
34,06234 503 USD |
6 885 -0.2% | 34,06 | 234 503 USD | |
2021-04-01 | 2021-03-30 |
Ikena Oncology Inc
(IKNA)
|
A Achat |
48 400
+70.2%
16,00774 400 USD |
48 400 +70.2% | 16,00 | 774 400 USD | |
2021-04-01 | 2021-03-30 |
Ikena Oncology Inc
(IKNA)
|
A Achat |
375 000
+20.6%
16,006 000 000 USD |
375 000 +20.6% | 16,00 | 6 000 000 USD | |
2020-08-12 | 2020-08-10 |
Acutus Medical Inc
(AFIB)
|
A Achat |
41 500
+inf%
18,00747 000 USD |
41 500 +inf% | 18,00 | 747 000 USD | |
2020-08-12 | 2020-08-10 |
Acutus Medical Inc
(AFIB)
|
A Achat |
373 500
+inf%
18,006 723 000 USD |
373 500 +inf% | 18,00 | 6 723 000 USD | |
2020-06-25 | 2020-06-23 |
Repare Therapeutics Inc
(RPTX)
|
A Achat |
99 200
+inf%
20,001 984 000 USD |
99 200 +inf% | 20,00 | 1 984 000 USD | |
2020-06-25 | 2020-06-23 |
Repare Therapeutics Inc
(RPTX)
|
A Achat |
675 000
+25.9%
20,0013 500 000 USD |
675 000 +25.9% | 20,00 | 13 500 000 USD | |
2020-03-16 | 2020-03-12 |
Imara Inc
(IMRA)
|
A Achat |
937 500
+inf%
16,0015 000 000 USD |
937 500 +inf% | 16,00 | 15 000 000 USD | |
2019-04-05 | 2019-04-03 |
Tricida Inc
(TCDA)
|
A Achat |
225 000
+2.1%
36,008 100 000 USD |
225 000 +2.1% | 36,00 | 8 100 000 USD |